Stay updated on STK-012 in Solid Tumors with Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Added a new Revision: v3.3.3 entry; removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T07:58:00.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    STK-012 Monotherapy and in Combination Therapy in Patients With Solid Tumors was replaced with a broader 'Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers (SYNERGY-101)'. The update adds or updates sections including Contacts/Locations, Eligibility, Outcome Measures, Arms and Interventions, Study Design, Conditions, Study Description, Oversight, Study Status, and Study Identification.
    Difference
    1%
    Check dated 2025-12-01T15:11:16.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    A new revision v3.3.1 was added to the study record history, and the v3.2.0 revision was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T12:38:36.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The government funding lapse notice regarding operating status and updates has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2025-11-17T06:22:27.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    The new screenshot shows the same page with minor visual adjustments to header spacing and table presentation, and no substantive changes to study data or history entries. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T00:58:39.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    Update includes a new v3.2.0 release with a government funding status notice and operating status details; removes the old v3.1.0 reference.
    Difference
    12%
    Check dated 2025-10-05T09:55:55.000Z thumbnail image

Stay in the know with updates to STK-012 in Solid Tumors with Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page.